TD Private Client Wealth’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-98,390
Closed -$161K 1249
2024
Q1
$161K Hold
98,390
0.01% 624
2023
Q4
$56.6K Hold
98,390
﹤0.01% 799
2023
Q3
$39.4K Hold
98,390
﹤0.01% 809
2023
Q2
$53.4K Hold
98,390
﹤0.01% 769
2023
Q1
$83.9K Hold
98,390
﹤0.01% 678
2022
Q4
$128K Hold
98,390
0.01% 595
2022
Q3
$175K Hold
98,390
0.01% 545
2022
Q2
$223K Hold
98,390
0.01% 514
2022
Q1
$325K Hold
98,390
0.01% 481
2021
Q4
$448K Hold
98,390
0.02% 438
2021
Q3
$706K Hold
98,390
0.03% 365
2021
Q2
$790K Sell
98,390
-10,000
-9% -$84.4K 0.03% 356
2021
Q1
$736K Buy
+108,390
New +$721K 0.03% 349

Other funds holding OCGN

TD Private Client Wealth's OCGN Position: Q2 2024 in Review

TD Private Client Wealth sold out of Ocugen (OCGN) in Q2 2024, closing a stake of 98,390 shares — an estimated $161K sold.

TD Private Client Wealth first reported a position in OCGN in Q1 2021 and held it in 13 quarters. The position peaked at $790K in Q2 2021. 101 funds tracked by Wall St. Rank hold OCGN as of Q2 2024.

  • TD Private Client Wealth reported no remaining Ocugen position as of Q2 2024 after selling out during the quarter.
  • TD Private Client Wealth sold 98,390 Ocugen shares in Q2 2024, an estimated $161K.
  • TD Private Client Wealth first reported a position in Ocugen in Q1 2021 and held it in 13 quarters.
  • TD Private Client Wealth's Ocugen position peaked at $790K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Ocugen as of Q2 2024.

Based on TD Private Client Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.